Obexelimab (XmAb5871) is a bifunctional monoclonal antibody that binds CD19 and FcyRIIb, inhibits B-cells, plasmoblasts, and plasma cells, and may be used in the study of autoimmune diseases such as systemic lupus erythematosus.
Purity:
100.00%
CAS Number:
[1690307-05-1]
Target:
Immunology/Inflammation related|||Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted